舊金山確診首例第一分支猴痘病例
San Francisco confirms first case of Clade 1 Mpox
2026年4月14日，舊金山公共衛生局確認了該市首例第一分支(Clade I)猴痘病例。
On April 14, 2026, the San Francisco Department of Public Health confirmed the city's first case of Clade I mpox.
該名患者為一名未接種疫苗的成年人，曾需住院治療，目前正在康復中。
The patient, an unvaccinated adult, required hospitalization but is currently recovering.
衛生官員指出，該病毒是透過與一名國際旅客的密切接觸而傳播。
Health officials note that the virus was transmitted via close contact with an international traveler.
兩種病毒株的症狀相似，通常以類流感跡象開始，隨後出現皮疹。
Symptoms for both strains are similar, often beginning with flu-like signs followed by a rash.
醫學專家強調，JYNNEOS疫苗對這兩種分支皆有效，並強烈建議高風險族群完成兩劑系列接種。
Medical experts stress that the JYNNEOS vaccine is effective against both clades and strongly advise those at higher risk to complete their two-dose series.
對於計畫前往國外旅遊或參加大型公共活動的民眾來說，這一點尤為重要。
This is especially important for those traveling internationally or attending large public events.
臨床醫生也被敦促對近期有國際旅遊史的患者保持警惕。
Clinicians are also urged to remain alert for potential cases in patients with recent international travel history.
截至2026年初，第二分支(Clade II)在舊金山仍以低水平持續傳播，但此病例對當地公共衛生當局而言是一個重大的發展。
As of early 2026, Clade II continues to circulate at low levels in San Francisco, but this marks a significant development for local public health authorities.
